文献速递糖尿病垂体与肾上腺疾病

新发2型糖尿病合并高血压患者中原发性醛固酮增多症的患病率

Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

本研究对256例新发2型糖尿病合并高血压门诊患者进行原发性醛固酮增多症(PA)筛查,采用ARR≥30 ng/dL/ng/mL/h且PAC≥15 ng/dL作为筛查阳性,并经卡托普利激发试验确诊。结果显示筛查阳性99例(39%),确诊PA 49例(19%)。PA患者收缩压≥160 mmHg比例更高、高血压家族史更少、血钾更低;HOMA-IR与PAC水平正相关。

要点

  • 新发2型糖尿病合并高血压患者中PA患病率至少为19%。
  • 筛查阳性标准为ARR≥30 ng/dL/ng/mL/h且PAC≥15 ng/dL。
  • 糖尿病患者的HOMA-IR与PAC水平呈正相关。

核心结论

  • 新发2型糖尿病合并高血压患者中PA的患病率至少为19%。
  • 较高的醛固酮水平可能与糖尿病患者的胰岛素抵抗相关。

研究设计与样本

  • 研究纳入256例新发2型糖尿病合并高血压门诊患者,进行PA筛查。
  • 测定血浆醛固酮浓度(PAC)和血浆肾素活性(PRA)。
  • 筛查阳性者(ARR≥30 ng/dL/ng/mL/h且PAC≥15 ng/dL)接受卡托普利激发试验(CCT)确诊。

主要发现

  • 256例连续患者中,99例(39%)筛查试验阳性,49例(19%)确诊PA。
  • 与A组(筛查阴性)和B组(筛查阳性但CCT阴性)相比,C组(确诊PA)患者收缩压≥160 mmHg的比例更高、高血压家族史更少、血清钾更低。
  • B组和C组患者的PAC和ARR水平高于A组,但PRA低于A组。
  • 在糖尿病患者中,HOMA-IR与PAC水平呈正相关。

关键数值与推荐

  • PA筛查标准:ARR≥30 ng/dL/ng/mL/h且PAC≥15 ng/dL。
  • PA诊断标准(CCT后):PAC下降<30%,ARR维持≥30 ng/dL/ng/mL/h,且PAC≥11 ng/dL。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Despite a high prevalence of hypertension in diabetes and close relationship between primary aldosteronism (PA) and glucose metabolism, few study concerns the prevalence of PA in diabetes with hypertension. OBJECTIVE: This study aimed to detect the prevalence of PA in patients with new-onset type 2 diabetes (T2D) and hypertension and to explore the association between PA and diabetes. METHODS: A total of 256 outpatients with new-onset T2D and hypertension were screened for PA. Plasma aldosterone concentration (PAC), plasma renin activity (PRA) were measured. Patients with an aldosterone renin activity ratio (ARR) ≥ 30 ng/dL/ng/mL/h and PAC ≥ 15 ng/dL underwent confirmatory captopril challenge test (CCT) for PA. The diagnostic criteria for PA were, after CCT, (1) PAC decreased < 30%, (2) ARR maintained ≥ 30 ng/dL/ng/mL/h, and (3) PAC was ≥ 11 ng/dL. RESULTS: Of 256 consecutive patients, 99 (39%) were positive for the screening test, and 49 (19%) were diagnosed with PA. Compared with those in groups A (screening test -) and B (screening test +, CCT -), patients in group C (diagnosed with PA) had a higher percentage of systolic blood pressure of ≥ 160 mmHg, less family history of hypertension, and lower serum potassium. Patients in group B and C had higher PAC and ARR levels, but lower PRA than those in group A. Homeostatic model assessment for insulin resistance (HOMA-IR) was positively associated with PAC level among the diabetic patients. CONCLUSION: The prevalence of PA in new-onset T2D patients with hypertension is at least 19%. Higher aldosterone may be related with insulin resistance in patients with diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Hu Y, Zhang J, Liu W, et al. Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension. J Clin Endocrinol Metab. 2020. PMID: 32163576. doi:10.1210/clinem/dgz293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。